𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety pharmacology program for pharmaceuticals

✍ Scribed by Lewis B. Kinter; Lon W. Dixon

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
405 KB
Volume
35
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Manufacturing of Pharmaceutical Proteins
Manufacturing of Pharmaceutical Proteins || Pharmacology and Drug Safety
✍ Behme, Stefan πŸ“‚ Article πŸ“… 2009 πŸ› Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German βš– 226 KB

Risk-benefit evaluation ## Clinical development determines the speed of product development Manufacturing process should be fixed before phase III j139

Program development for safety tests
Program development for safety tests
✍ L. Hub; T. Kupr; E. Staeheli πŸ“‚ Article πŸ“… 1979 πŸ› Elsevier Science 🌐 English βš– 269 KB
General pharmacology studies in the phar
General pharmacology studies in the pharmaceutical industry: Example of a basic program
✍ Michel Pairet; Willi Diederen; Brian Guth; Kozo Kanai; Annerose Mauz; Michael Pi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

The objectives of general pharmacology (GP) studies from the point of view of pharmacologists working in the pharmaceutical industry are presented and compared with the requirements of regulatory authorities, using the Japanese Guidelines as an example. Based on these requirements, as well as the in